The Diagnostic Imaging CT modality focus page provides information, videos, podcasts, and the latest news about industry product developments, trial results, screening guidelines, and protocol guidance that touch on the use of CT across the healthcare continuum, from various cancer screenings, such as lung and colon, to cardiothoracic imaging, to appendicitis, and more.
November 20th 2024
While a large retrospective study found that interstitial lung abnormalities (ILAs) were evident on 1.7 percent of computed tomography (CT) scans, researchers found that 43.9 percent of ILAs, including fibrotic ILAs, were not reported.
19th Annual New York Lung Cancers Symposium®
November 16, 2024
Register Now!
Medical Crossfire®: How Does Recent Evidence on PARP Inhibitors and Combinations Inform Treatment Planning for Prostate Cancer Now and In the Future?
View More
Medical Crossfire®: How Do the Experts Select and Sequence Therapies to Optimize Patient Outcomes and Quality of Life in Advanced Prostate Cancer?
View More
Lung Cancer Tumor Board®: Enhancing Multidisciplinary Communication to Optimize Immunotherapy in Stage I-III NSCLC
View More
Clinical Vignettes™: The Experts Explain How They Integrate PET Imaging into Metastatic HR+ Breast Cancer Care Settings
View More
School of Breast Oncology® Live Video Webcast: Clinical Updates from San Antonio
View More
Annual Hawaii Cancer Conference
January 25-26, 2025
Register Now!
21st Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
February 8, 2025
View More
Community Practice Connections™: The 2nd Annual Hawaii Lung Cancers Conference®
View More
18th Annual New York GU Cancers Congress™
March 28-29, 2025
Register Now!
Clinical Case Vignette Series™: 41st Annual Miami Breast Cancer Conference®
View More
Medical Crossfire®: How Can Thoracic Teams Facilitate Optimized Care of Patients With Stage I-III EGFR Mutation-Positive NSCLC?
View More
Lung Cancer Tumor Board®: How Do Emerging Data for ICIs, BiTEs, ADCs, and Targeted Strategies Address Unmet Needs in the Therapeutic Continuum for SCLC?
View More
26th Annual International Lung Cancer Congress®
July 25-26, 2025
Register Now!
2025 International Symposium of Gastrointestinal Oncology (ISGIO)
September 12-13, 2025
Register Now!
Lung Cancer Tumor Board: Enhancing Precision Medicine in NSCLC Through Advancements in Molecular Testing and Optimal Therapy Selection
View More
(CME Credit Only) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
(MOC and CME Credit) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
(CME Credit Only) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
(MOC and CME Credit) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
Nuclear medicine tackles DICOM connectivity issues
October 2nd 2001A group of nuclear medicine cardiologists and others who use nuclear medicine data have formed an ad hoc task force to encourage vendors to improve their DICOM software and work with each other to test their DICOM connectivity. Members of the task
Toshiba uses Internet to generate sales leads at SNM meeting
August 8th 2001Among the many ways that corporations hoped the Internet might save them money, no one considered its potential for reducing baggage—until Toshiba America.Rather than lug gamma cameras to the Toronto annual meeting of the Society of Nuclear
CMS coverage decision favors dedicated PET scanners
July 25th 2001The worst fears of owners and vendors of coincidence cameras were confirmed on June 29, when the Centers for Medicare and Medicaid Services (CMS) formally restricted reimbursement to selected types of nuclear medicine devices.Expanded PET applications
MDS Nordion gets set to build Canadian cyclotron
July 8th 2001In a bid to expand its capacity to make certain key radioisotopes for use in nuclear medicine, MDS Nordion plans to invest $20 million to build a cyclotron in Vancouver, BC. The atom smasher, when completed in January 2003, could double the
Detector materials drive increased PET productivity
July 8th 2001The U.S. market may soon welcome two new dedicated PET scanners under four different labels. The scanners, formally launched at the annual meeting of the Society of Nuclear Medicine in Toronto, are remarkable for the materials built into their detectors,
Syncor subsidiary acquires Radpharm Scientific
July 8th 2001An Australian subsidiary of Syncor has acquired Radpharm Scientific, distributor and manufacturer of diagnostic radiopharmaceuticals. Based in Canberra, Radpharm distributes its products to more than 160 nuclear medicine practices in Australia and
CT/positron scanners highlight vendor exhibits at SNM annual meeting
July 8th 2001Hybrid PET/CT scanners provided the excitement at the mid-June annual meeting of the Society of Nuclear Medicine. Vendors, led by GE Medical Systems—and its pre-SNM media blitz—hyped the clinical and economic importance of their newly
Radiotherapy dominates products cleared by FDA in April
June 6th 2001Nearly a third of the 25 radiology-related applications passing FDA muster in April address radiation oncology. The rest were split among MRI, ultrasound, image management, and nuclear medicine. Standouts included two ultrasound systems, an x-ray
Nuclear cardiology sites come aboard
May 9th 2001Adding to its investment in positron imaging, Integral Nuclear Associates has purchased the assets of Nuclear Imaging Systems and Cardiovascular Concepts. These assets include 14 fixed-site nuclear cardiology imaging centers in Pennsylvania, New Jersey,
Howtek partners with Nuclear Associates
May 9th 2001Nuclear Associates, a division of Inovision, has agreed to exclusively offer Howtek MultiRAD medical film digitizers. The digitizers will be marketed alongside Nuclear Associates’ radiation oncology and diagnostic products, which include quality
Nycomed releases lung agent in Europe
April 25th 2001NeoSpect, a product for noninvasive diagnosis of suspected lung cancer, has entered the European market. The nuclear medicine product has been on the U.S. market since 1999 under the trade name NeoTect, which is being comarketed by Nycomed Amersham and
In vitro diagnostics: natural next choice for M&A
January 31st 2001The obvious targets for merger and acquisition are gone. The flurry of purchases undertaken in 2000 pretty much cleared the deck of single-modality vendors. SMV is part of GE; ADAC Laboratories has become the nuclear medicine division of Philips; Agilent
Nuclear medicine regs face fresh opposition
January 17th 2001Rankled by proposed revisions to the long-standing regulations that govern diagnostic nuclear medicine, two trade organizations have filed a joint petition asking the Nuclear Regulatory Commission to revoke a portion of a pending rule that would impose
Philips puts up $426 million to acquire nuclear leader ADAC Laboratories
November 22nd 2000By Robert BruceRoyal Philips Electronics announced last week that it has agreed to acquire ADAC Laboratories for $426 million, or $18.50 a share of ADAC's outstanding common stock. The offer is subject to regulatory approval. It is good until Dec. 12 and
Siemens claims top market share among nuclear medicine companies
November 8th 2000Company shows big growth in PET and gamma cameras Based in large part on substantial sales growth for its PET and gamma camera products, Siemens Medical Systems has laid claim to the top market share spot worldwide in nuclear medicine.Siemens
SMV receives first FDA clearance for PET/CT hybrid system
September 13th 2000SMV’s Positrace, the first commercially available PET/CT system, obtained FDA 510(k) clearance Sept. 1, just days before the European Association of Nuclear Medicine meeting began in Paris.Although GE Medical Systems has a 510(k) clearance for its
GE to acquire Elscint’s share in ELGEMS
September 13th 2000GE Medical Systems and Elscint have reached an agreement in which GE will acquire Elscint’s 50% share of ELGEMS, a joint venture formed in 1997 by the two companies to manufacture nuclear imaging systems, for $30 million.As a result of the
Marconi unveils single-head gamma camera
August 16th 2000Marconi Medical Systems has a new offering in its line of nuclear medicine products. The single-head system, called Meridian, complements the existing line of dual- and triple-head cameras that have become the company’s standard bearers.Meridian
Marconi testing MR and NM oncology tools
August 2nd 2000Marconi Medical Systems is expanding its oncology business beyond CT to MR and nuclear medicine with new screening tools and is signing business agreements with several companies and international health centers.Marconi formally launched its
SMV expects clearance for PET/CT this summer
July 5th 2000At this year’s Society of Nuclear Medicine meeting, imaging systems that fused PET with CT was a feature seen at a few vendor booths, including GE and SMV of Ohio. SMV displayed a combination PET/CT system called Positrace that was first seen at
Syncor inks three deals to expand nuclear medicine base
June 21st 2000Will increase FDG output and sales forcePharmaceutical manufacturer Syncor of Woodland Hills, CA, struck three deals this month that will expand its presence and customer base in the nuclear medicine industry. The company aims to build the
ADAC to ship Skylight sometime after October
June 7th 2000ADAC Laboratories has a first customer for its recently approved Skylight nuclear medicine camera: Cedars-Sinai Medical Center in Los Angeles.Cedars-Sinai placed an order for the $1 million imaging device, along with a C-PET positron emission
SNM announces deal with GE for Web-based CME project
May 10th 2000The Society of Nuclear Medicine announced its first exclusive alliance with a single industry vendor when it joined with General Electric Medical Systems to develop educational programs for the nuclear medicine community.According to the agreement, the